Caroline Oktarina; Danny Surya; Putu Martha Gerynda Sukma; Teguh Hopkop Putera Manurung; Sandra Widaty
Abstract
Background: Scabies is an infestation caused by Sarcoptes scabiei var. hominies, prevalent in children with poor nutritional status and hygiene, particularly in overcrowded communities. Indonesia has 14.5% cases of the double burden of malnutrition among school-aged children. As there has been no study ...
Read More
Background: Scabies is an infestation caused by Sarcoptes scabiei var. hominies, prevalent in children with poor nutritional status and hygiene, particularly in overcrowded communities. Indonesia has 14.5% cases of the double burden of malnutrition among school-aged children. As there has been no study establishing the role of nutritional status in the occurrence of scabies, this study aims to investigate the association between body mass index (BMI) and height with scabies infestation in an Islamic boarding school in Indonesia.Methods: This was a cross-sectional study conducted in an Islamic boarding school in Indonesia with children aged 11-17 years old as participants. Physicians performed anthropometry measurements, and a dermatologist confirmed the diagnosis of scabies through history taking and physical examination. Logistic regression was used to analyze the association between BMI and height and the prevalence of scabies.Results: Of 287 subjects, 135 (47%) were diagnosed with scabies, with a male predominance (66.1%). Most of the subjects had normal weight (76.7%) while 20 (7%) were underweight, and 153 subjects (53.3%) had short stature. Male subjects were four times more likely to be infested by scabies (P < 0.001). Obese and short subjects were 4 and 1.67 times more likely to develop scabies, respectively.Conclusion: Poor nutritional status represented by BMI and height cannot be regarded as an independent risk factor for scabies, while environmental factors might be the most crucial factors in the development of scabies. A holistic approach addressing these factors should be implemented to eradicate scabies in addition to appropriate pharmacological management.
Shahla Babae Nejad; Neda Yousefi; Hamideh Herizchi; Effat Khodaeiani; Mohamad Sadeghi; Mohamad Goldust
Volume 13, Issue 3 , 2010, , Pages 87-90
Abstract
Background: Scabies is one of the health care problems in our community and is an endemic problem at any time. Its current therapy in Iran is lindane 1% lotion, which is deleted from market in many countries because of multiple side effects and better alternatives. The aim of this study was to evaluate ...
Read More
Background: Scabies is one of the health care problems in our community and is an endemic problem at any time. Its current therapy in Iran is lindane 1% lotion, which is deleted from market in many countries because of multiple side effects and better alternatives. The aim of this study was to evaluate the efficacy and side effects of lindane in patients with scabies and to replace lindane with other safer and more effective scabicides in case of high treatment failure rates.Method: 100 patients with clinical diagnosis of scabies were treated with two lindane 1% lotions with an interval of one week. The patients were examined two and four weeks after the initial treatment in order to evaluate clinical cure. Data was analyzed with SPSS-13.Results: The mean age of the patients was 33.74 years. Of them, 52% were male and 48% were female, 60% were married and close contact was found in 100% of the patients as the route of transmission of the disease. Symptoms reduced in 75% of the patients after two times of applying lindane. Itching decreased 3 days after applying Lindane and disappeared completely on the seventh day. Fifty four percent were free of disease 28 days after treatment.Conclusion: In this study, the failure rate of treatment with lindane was relatively high; therefore, it seems necessary to think of other alternative scabicides (such as permethrin 5% cream) for the treatment of scabies. Furthermore, with accurate usage, lindane is a safe topical modality and we found no adverse effects related to lindane.
J Golchai; O Zargari; M Gholipour; M Karbasi
Volume 7, Issue 1 , 2003, , Pages 29-32
Abstract
Background: Scabies is a contagious skin disorder and one of the most common itching dermatoses in whole of the world. Epidemiologic survey of scabies periodically done in many countries is a reflection of general status of public health in the community. Objective: To determine the prevalence of the ...
Read More
Background: Scabies is a contagious skin disorder and one of the most common itching dermatoses in whole of the world. Epidemiologic survey of scabies periodically done in many countries is a reflection of general status of public health in the community. Objective: To determine the prevalence of the scabies and its relationship with age, sex family size and place of residence. Patients & Methods: In this observational-cross sectional study on the students of primary schools in Somea-Sara in 2000-2001, 3656 students (On the basis of stratified random sampling) were selected and examined. The diagnosis of scabies was made on the basis of clinical criteria and the demographic data were recorded. Results: 50 out of 3656 students (1.36%) were suffered from scabies. The prevalence of scabies was 1.0% in urban schools and 1.61% in rural schools, 1% in male students and 1.7% in female students. The most common age group was 8-9 years and the mean of family size in patients was 6.1 and 6.2 in urban and rural areas, respectively. Conclusion: This study indicated that prevalence of scabies is higher in lower socio-economic state and larger family size.
M Eslami Danesh Pajooh; F Jafari; M Farivar Sadri; M Valikhani
Volume 3, Issue 2 , 2000, , Pages 10-15
Abstract
Background: Oral ivermectin is recently introduced for the treatment of scabies. Objective: The objective of this clinical trial was to compare the efficacy and safety of oral ivermectin and topical Gamma Benzene Hexachloride (GBH) 1% for the treatment of scabies. Patients and Methods: Fifty-eight cases ...
Read More
Background: Oral ivermectin is recently introduced for the treatment of scabies. Objective: The objective of this clinical trial was to compare the efficacy and safety of oral ivermectin and topical Gamma Benzene Hexachloride (GBH) 1% for the treatment of scabies. Patients and Methods: Fifty-eight cases were randomly assigned in the two treatment groups. In the ivermectin group, patients received a single oral dose of the drug (200 µg/kg). In the case of any signs of active disease, a second dose was administered one week later. All the patients in the GBH group received two topical applications of the drug, one week apart. The patients were seen after 48 hours, 1, 2, and 4 weeks. Results: Of the 37 patients treated with ivermectin, 27 (73%) showed clinical cure with a single dose and 10 (27%) required a second dose one week later. In the 21 patients treated with GBH, 18 (85.7%) received two applications of GBH, and three cases (14.3%) were cured by an additional curse of precipitated sulfur 6%. No serious side effects were seen in either group. The mean time for the drop of pruritus, the sense of well being and the healing of lesions, were each shorter with ivermectin than GBH, and the differences were statistically significant. Conclusion: Although all of the patients treated with ivermectin or topical GBH were cured, ivermectin cured faster than topical treatment.